Abbvie Inc.

Abbott Laboratories Corporation

Other

Monsanto Company

B/e Aerospace, Inc.

Abbott Products Gmbh

Ligand Pharmaceuticals, Inc.

Abbvie Bahamas Limited

Abbvie Ireland Unlimited Company

John K Pratt

Dachun Liu

Todd Warren Rockway

Clarence J Maring

David A Betebenner

Rolf Wagner

Allan C Krueger

Douglas K Hutchinson

Warren M Kati

Pamela L Donner

David A DeGoey

John T Randolph

Charles A Flentge

Keith F McDaniel

Kenton L Longenecker

William A Carroll

Kent D Stewart

Le Wang

George S Sheppard

Lisa A Hasvold

Kevin R Woller

Charles W Hutchins

Philip R Kym

Geoff G Z Zhang

Anthony Ralph Haight

David M Barnes

Dale J Kempf

Daniel W Norbeck

Chen Zhao

William J McClellan

Robert A Mantei

James Patrick Edwards

Todd Kevin Jones

Steven Elmore

Martin Winn

Michael D Wendt

Rodger F Henry

Larry L Klein

Howard E Morton

Matthew James Graneto

Robert J Altenbach

Michael R Schrimpf

Michael D Tufano

Christopher E Motter

Yi Gao

Sachin V Patel

Tammie K Jinkerson

Mark A Matulenko

Ryan G Keddy

Kathy A Sarris

Seble H Wagaw

Lissa T Nelson

Wenke Li

Shuang Chen

William R Baker

Xiaochun Lou

Geoff G Zhang

James H Holms

Brian E Green

Rong Zhang

Uwe Schoen

Curt S Cooper

Yujia Dai

Darold L Madigan

Jason P Shanley

David D Anderson

Carol K Wada

Axel Pahl

Michael E Kort

Ming Clinton Yeung

Anthony K Fung

Jyoti R Patel

Tami J Pilot-Matias

Jimmie L Moore

Andrew Bogdan

David J Grampovnik

John Williamson

Hui-Ju J Chen

David L Arendsen

Irini Akritopoulou-Zanze

Fatima Z Basha

Daniel J Plata

Robert Hubbard

Chang H Park

Dennis Paul Phillion

Kevin B Sippy

Todd M Hansen

Irene I Drizin

Gerhard H Alt

Michael D Meyer

Robin R Frey

Sai Chi Wong

M Robert Leanna

Karin Rosemarie Tietje

James F Kerwin

Justin D Dietrich

Kim A Reynolds

Vincent S Stoll

William J Flosi

A gutter hanger includes a main body; a rear clip at a first end of the main body; a front hook at a second end of the body; at least one guide tab extending from the main body, the at least one guide tab sized and positioned to align a drive tool relative to the main body.

Gutter hanger with guide tab

The present invention provides for compounds of formula (I) wherein R, R, R, R, R, X, and Xhave any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I).

Bromodomain inhibitors

Compounds effective in inhibiting replication of Hepatitis C virus ('HCV') are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

Anti-viral compounds

The present invention provides for compounds of formula (I) wherein R, R, R, Y, Y, A, A, Aand Ahave any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I). 

Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors

The present invention provides for compounds of formula (I) wherein R, X, Y, Y, L, A, A, A, A, A, A, A, and A, have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I). 

The present invention provides for compounds of formula (I) wherein A, Y, J, R, R, and Rhave any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.

Isoindolone derivatives

This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Antiviral compounds and uses thereof

This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Hepatitis C inhibitors and uses thereof

The present invention provides for compounds of formula (I) wherein A, A, A, A, J, and Xhave any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.

Pyridinone and pyridazinone derivatives

The present invention provides for compounds of formula (I) wherein R, R, R, and Rhave any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).

Pyrrole-3-carboxamide bromodomain inhibitors

Growing community of inventors

Kenosha, WI, United States of America

John K Pratt